ertapenem has been researched along with Kidney Failure, Chronic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arimuthu, DA; Mazlan, SA; Shahar, S | 1 |
| Ersoy, F; Uslu, H; Yılmaz, F | 1 |
| Deters, M; Kaever, V; Koal, T; Resch, K | 1 |
| Deutsch, PJ; Fisher, A; Hesney, M; Majumdar, AK; Mistry, GC; Sica, D; Swan, S; Wagner, JA; Xi, L; Xu, Y | 1 |
1 trial(s) available for ertapenem and Kidney Failure, Chronic
| Article | Year |
|---|---|
Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on hemodialysis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Area Under Curve; Aspartate Aminotransferases; beta-Lactams; Drug Administration Schedule; Ertapenem; Female; Half-Life; Humans; Infusions, Intravenous; Kidney; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Renal Insufficiency; Time Factors | 2006 |
3 other study(ies) available for ertapenem and Kidney Failure, Chronic
| Article | Year |
|---|---|
Ertapenem-induced neurotoxicity in an end-stage renal disease patient on intermittent haemodialysis: a case report.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ertapenem; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neurotoxicity Syndromes; Renal Dialysis; Renal Insufficiency, Chronic | 2022 |
Ertapenem Associated With Seizures in Treatment of Pyelonephritis in a Chronic Peritoneal Dialysis Patient.
Topics: Administration, Intravenous; Anti-Bacterial Agents; beta-Lactams; Drug Dosage Calculations; Ertapenem; Escherichia coli; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Pyelonephritis; Seizures | 2016 |
Quantification of the carbapenem antibiotic ertapenem in human plasma by a validated liquid chromatography-mass spectrometry method.
Topics: beta-Lactams; Calibration; Carbapenems; Chromatography, High Pressure Liquid; Drug Stability; Ertapenem; Humans; Kidney Failure, Chronic; Mass Spectrometry; Reference Standards; Reproducibility of Results | 2006 |